183 related articles for article (PubMed ID: 27855669)
1. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H; Nagasaka K; Kawana K; Taguchi A; Uehara Y; Yoshida M; Sato M; Nishida H; Fujimoto A; Inoue T; Adachi K; Nagamatsu T; Arimoto T; Oda K; Osuga Y; Fujii T
BMC Cancer; 2016 Nov; 16(1):897. PubMed ID: 27855669
[TBL] [Abstract][Full Text] [Related]
2. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
4. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism.
Dogra S; Neelakantan D; Patel MM; Griesel B; Olson A; Woo S
Mol Cancer Res; 2021 Sep; 19(9):1534-1545. PubMed ID: 34172534
[TBL] [Abstract][Full Text] [Related]
5. Defective expression of polarity protein Par3 promotes cervical tumorigenesis and metastasis.
Zheng JH; Jiao SJ; Na L; Zheng SQ; Ma ZH; Wang SW; Aili A; Hasim A
Eur J Gynaecol Oncol; 2017; 38(2):199-206. PubMed ID: 29953780
[TBL] [Abstract][Full Text] [Related]
6. Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.
Wang S; Cai J; Zhang S; Dong M; Zhang L; Xu Y; Shen B; Chen S
Cancer Sci; 2021 Jul; 112(7):2625-2641. PubMed ID: 33931921
[TBL] [Abstract][Full Text] [Related]
7. ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Gen Y; Yasui K; Kitaichi T; Iwai N; Terasaki K; Dohi O; Hashimoto H; Fukui H; Inada Y; Fukui A; Jo M; Moriguchi M; Nishikawa T; Umemura A; Yamaguchi K; Konishi H; Naito Y; Itoh Y
Cancer Lett; 2017 Jul; 398():52-61. PubMed ID: 28400336
[TBL] [Abstract][Full Text] [Related]
8. Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion.
Xue B; Krishnamurthy K; Allred DC; Muthuswamy SK
Nat Cell Biol; 2013 Feb; 15(2):189-200. PubMed ID: 23263278
[TBL] [Abstract][Full Text] [Related]
9. Loss of Par3 promotes lung adenocarcinoma metastasis through 14-3-3ζ protein.
Song T; Tian X; Kai F; Ke J; Wei Z; Jing-Song L; Si-Hua W; Jian-Jun W
Oncotarget; 2016 Sep; 7(39):64260-64273. PubMed ID: 27588399
[TBL] [Abstract][Full Text] [Related]
10. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
12. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
13. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
15. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
[TBL] [Abstract][Full Text] [Related]
16. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
17. Loss of the polarity protein PAR3 activates STAT3 signaling via an atypical protein kinase C (aPKC)/NF-κB/interleukin-6 (IL-6) axis in mouse mammary cells.
Guyer RA; Macara IG
J Biol Chem; 2015 Mar; 290(13):8457-68. PubMed ID: 25657002
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
20. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
